GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus

被引：0
|
作者：
Claire Greenhill
机构：
[1] Nature Reviews Endocrinology,
来源：
Nature Reviews Endocrinology | 2022年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：331 / 331
相关论文
共 50 条
  • [1] GLP1-oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus
    Greenhill, Claire
    NATURE REVIEWS ENDOCRINOLOGY, 2022, 18 (06) : 331 - 331
  • [2] Pancreatic α-Cells and Insulin-Deficient Diabetes
    Quesada, Ivan
    ENDOCRINOLOGY, 2016, 157 (02) : 446 - 448
  • [3] Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice
    Le May, Cedric
    Chu, Khoi
    Hu, Min
    Ortega, Christina S.
    Simpson, Evan R.
    Korach, Kenneth S.
    Tsai, Ming-Jer
    Mauvais-Jarvis, Franck
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (24) : 9232 - 9237
  • [4] MITOCHONDRIAL GENE MUTATION AND INSULIN-DEFICIENT TYPE OF DIABETES-MELLITUS
    KADOWAKI, H
    TOBE, K
    MORI, Y
    SAKURA, H
    SAKUTA, R
    NONAKA, I
    HAGURA, R
    YAZAKI, Y
    AKANUMA, Y
    KADOWAKI, T
    LANCET, 1993, 341 (8849): : 893 - 894
  • [5] Leptin therapy for insulin-deficient type 1 diabetes
    Jecht, M.
    DIABETOLOGE, 2010, 6 (03): : 214 - +
  • [6] Detection of Insulin in Insulin-Deficient Islets of Patients with Type 1 Diabetes
    Krivova, Yuliya
    Proshchina, Alexandra
    Otlyga, Dmitry
    Kharlamova, Anastasia
    Saveliev, Sergey
    LIFE-BASEL, 2025, 15 (01):
  • [7] GLOMERULAR HYPERFILTRATION (GH) IN CANINE INSULIN-DEFICIENT DIABETES-MELLITUS (DM)
    LIFSCHITZ, MD
    HURA, CE
    LANE, JM
    GARCIA, S
    STEIN, JH
    KUNAU, RT
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 512 - 512
  • [8] GLOMERULAR HYPERFILTRATION (GH) IN CANINE INSULIN-DEFICIENT DIABETES-MELLITUS (DM)
    HURA, CE
    LANE, JM
    GARCIA, S
    STEIN, JH
    KUNAU, RT
    CLINICAL RESEARCH, 1989, 37 (02): : A492 - A492
  • [9] Myostatin inhibition therapy for insulin-deficient type 1 diabetes
    Samantha K. Coleman
    Irena A. Rebalka
    Donna M. D’Souza
    Namita Deodhare
    Eric M. Desjardins
    Thomas J. Hawke
    Scientific Reports, 6
  • [10] Myostatin inhibition therapy for insulin-deficient type 1 diabetes
    Coleman, Samantha K.
    Rebalka, Irena A.
    D'Souza, Donna M.
    Deodhare, Namita
    Desjardins, Eric M.
    Hawke, Thomas J.
    SCIENTIFIC REPORTS, 2016, 6
12345